June 28, 2022

Contrast media shortage reveals cracks in supply chain

By: Tarsilla Moura
Share

May 2022 saw a critical shortage of the iodinated contrast medium (ICM) iohexol that extended well into June because of a COVID-19-related shutdown of a GE Healthcare plant in Shanghai, China, that interrupted the manufacture of ICM. According to the American College of Radiology, contrast media were added to the US Food and Drug Administration (FDA) drug shortage list on May 9.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

LOGIN

Not a subscriber? That’s OK, subscribe today! OR Manager offers all-access subscriptions at an affordable rate. With your subscription – or your team’s group subscription – you’ll receive access to all that OR Manager has to offer, including our monthly issues, CE credit opportunities, job postings, and discounts to our industry-leading conferences.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at clientservices@accessintel.com or 1-888-707-5814.

Live chat by BoldChat